Archives
Archives by Date
2010: Jan Feb Mar Apr May Jun Jul2009: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2008: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Archives by Category / Tag
- Articles
- Tags
- 2009 Hospital Inpatient Prospective Payment System Final Rule
- 340B Drug Pricing Program
- Advanced Medical Technology Association (AdvaMed Code)
- Adverse Events
- Advertising
- Agency for Healthcare Research and Quality (AHRQ)
- Alternative Methods Demonstration Project (AMDP)
- American Recovery and Reinvestment Act (ARRA)
- Anti-Competitive Conduct
- Anti-Kickback Statutes
- Antitrust
- Arbitration
- Article 21 of Regulation No.1924/2006
- Assisted Living Facilities
- Attorney General
- Attorney Work Product
- Attorney-Client Privilege
- Bad Ad Program
- Buckman
- CPSC
- California
- California Code of Civil Procedure
- California Supreme Court
- Carbon Nanotubes
- Causation
- Centers for Disease Control and Prevention (CDC)
- Centers for Medicare and Medicaid (CMS)
- Centers for Medicare and Medicaid Services
- Centers for Medicare and Medicaid Services (CMS)
- Chairman Henry A. Waxman
- China
- Civil Justice Reform
- Clawback
- Clinical Laboratories
- Colacicco
- Committee on Energy and Commerce
- Community Benefits
- Comparative Effectiveness
- Compliance
- Conflicts of Interest
- Consolidated Omnibus Budget Reconciliation Act (COBRA)
- Consumer Product Safety Improvement Act of 2008 (CPSIA)
- Consumer Protection Statutes
- Consumer Rights Protection Law
- Consumer-Product Safety Commission (CPSC)
- Continuing Medical Education
- Counterfeit Medicine
- Cuban Assets Control Regulations (CACR)
- DMEPOS
- Data Protection and Privacy
- Department of Health and Human Services (HHS)
- Department of Justice (DOJ)
- Department of Veterans Affairs
- Department of Veterans Affairs (VA)
- Diagnostic Imaging
- Direct to Consumer Advertising (DTC)
- Discovery
- Disproportionate Share Hospital (DSH) Payments
- Division for Drug Marketing, Advertising and Communications
- Division for Drug Marketing, Advertising, and Communications (DDMAC)
- Drug Pricing
- Drug Safety
- Drugs
- E-Discovery
- E-Verify
- EU Directive 2001/83/EC
- EU Regulation 507/2006I
- EU Regulation 726/2004
- Electronic Discovery Act
- Electronic Health Records
- Electronic Health Records (EHR)
- Electronically Stored Information (ESI)
- Employment
- Endorsements and Testimonials
- European Chemical Agency (ECHA)
- European Chemical Industry Council (Cefic)
- European Commission
- European Commission Pharmaceutical Package
- European Court of Justice
- European Medicines Agency
- European Union
- Executive Compensation
- Exports
- Express Preemption
- FDA
- FDA Commissioner Andrew C. von Eschenbach, M.D.
- FDA's Good Importer Practices Guidance
- Failure to Warn
- False Advertising
- False Claims Act
- False Claims Correction Act of 2009 (H.R. 1788)
- Federal Acquisition Regulation
- Federal Communications Commission (FCC)
- Federal Debt Collection Act
- Federal Institute of Information Access and Data Protection (FIIADP)
- Federal Law for Protection of Personal Data (FLPPA)
- Federal Trade Commission (FTC)
- Final Breach Notification Rule
- Food Safety Law
- Food and Drug Administration (FDA)
- Food and Drug Administration Amendements Act of 2007 (FDAAA)
- Food, Drug and Cosmetic Act
- Food, Drug and Cosmetic Act (FDCA)
- Foreign Corrupt Practices Act
- Forum Non Conveniens
- France
- Fraud Enforcement and Recovery Act of 2009 (S. 386)
- Good Reprint Practices
- Government Contracts
- Government Investigations
- Group Health Plans
- H.R. 1346
- H.R. 1424
- H.R. 3162
- H.R. 6331
- HIPAA
- HIPAA Privacy and Security Rules
- Health Canada
- Health Care Reform
- Health Care and Education Reconciliation Act of 2010 (The Reconciliation Act)
- Health Information Technology (Health IT)
- Health Information Technology for Economic and Clinical Health Act (HITECH)
- Health Research
- Health Resources and Services Administration (HRSA)
- Home Care Agencies
- Hospital Outpatient Clinics
- Hospitals
- IRS Hospital Compliance Project
- Implanted Neuromuscular Stimulators
- Implied Preemption
- Import Safety
- Imports
- In re Tobacco
- In-Patient Prospective Payment System (IPPS)
- Income Tax Exemptions
- Insurance Coverage
- Intellectual Property
- Internal Revenue Service (IRS)
- Iqbal
- Joint Ventures
- Lanham Act
- Law of the Case
- Legislation
- Long-Term Care Hospital (LTCH)
- Long-term Care Facilities
- MMSEA
- Managed Care Organizations (MCO)
- Mandatory Disclosure Rule
- Mandatory Reporting
- Market Share Liability
- Marketing
- Massachusetts Act to Promote Cost Containment
- Massachusetts Department of Public Health
- Medicaid
- Medicaid Rebate Statute
- Medical Device Amendments of 1976 (MDA)
- Medical Device Radiocommunication Service (MedRadio Service)
- Medical Device Safety Act of 2009
- Medical Devices
- Medical Micro-power Networks (MMNs)
- Medicare
- Medicare Advantage
- Medicare Improvements for Patients and Providers Act (MIPPA)
- Medicare Part D Drugs
- Medicare Recovery Audit Contractor (RAC)
- Medicare secondary payer (MSP)
- Memorandum for the Heads of Executive Departments and Agencies
- Mental Health Parity
- Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA)
- Mexico
- Ministry of Health of the People's Republic of China
- Ministry of Human Resources and Social Security (MOHRSS)
- Monitor
- Multidistrict Litigation
- Nanotechnology
- National Broadband Plan
- National Defense Authorization Act (NDAA)
- National Essential Drug List (NEDL)
- National Essential Drug System (NEDS)
- National Health Service (NHS)
- National Institute for Occupational Safety and Health (NIOSH)
- National People's Congress of China
- National People's Congress of the People's Republic of China
- Office of Foreign Assets Control (OFAC)
- Office of Inspector General (OIG)
- Office of Pharmacy Affairs (OPA)
- Outpatient Surgical Facilities
- Over-the-counter
- Patent
- Patient Protection and Affordable Care Act of 2010 (PPACA)
- Pennsylvania Department of Health
- Pennsylvania Department of Public Welfare (DPW)
- Pennsylvania Health Care Facilities Act
- PhRMA Code
- Pharmaceutical Research and Manufacturers of America (PhRMA)
- Pharmaceuticals
- Pharmacovigilance
- Pharmacy and Pharmacist
- Post-Market Surveillance
- Premarket Approval
- Prescription Drug Price Regulation
- Privacy
- Product Quality Law
- Promotional Activities
- Property Tax Exemptions
- Proposition 64
- Protected Health Information (PHI)
- Qui tam
- Radiology
- Recall
- Red Flag Regulation
- Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)
- Regulatory Compliance
- Regulatory Enforcement
- Reminder Items
- Riegel
- Riegel v. Medtronic
- Rule 502
- S. 2450
- S. 540
- SCHIP
- Sales Representatives
- Section 111
- Section 17200
- Section 340B Covered Entities
- Sedona Conference Best Practices
- Self-Critical Analysis Privilege
- Sentinel
- Social Media
- Sophisticated User Doctrine
- Stark Law
- State Administration of Industry and Commerce (SAIC)
- State Food & Drug Administration (SFDA)
- State Tax
- Substance Information Exchange Forum (SIEF)
- Supply Chains
- TRICARE
- Tax
- The Care and Quality Commission (CQC)
- Tort Liability Law
- Trademark Infringement
- Transfer of Venue
- Transparency and Efficiency in the Delivery of Quality Health Care
- Twombly
- U.S. Citizenship and Immigration Services (CIS)
- U.S. Department of Commerce
- U.S. Department of Health and Human Services (HHS)
- U.S. Department of Homeland Security
- U.S. Department of Labor
- UK Coalition Government
- UK Healthcare Reform
- Unfair Competition
- VHCA Federal Ceiling Price (FCP)
- Veterans Health Care Act (VHCA)
- Waiver
- Whistleblower
- Wireless Medical Devices
- Workplace Exposure
- World Health Organization (WHO)
- Wyeth v. Levine
- assisted living residences (ALRs)
- elder care
- general conformity certificates (GCCs)
- health technology
- licensure
- medical device manufacturers
- medical liability
- patient safety
- tort reform
- wage and hour
